It has been generally recognized that the main target of ANT antitumor action was topoisomerase IIα (TOP2α), through the formation of the Top2-ANT-DNA complex, which causes double-stranded DNA breaks [19–21], which are able to trigger the apoptosis of cancer cells, apparently via the p53-dependent pathway [22]. The gene discussed is TP53; the disease is cancer.